DAWNA-1研究:达尔西利联合氟维司群治疗HR+/HER2-晚期乳腺癌的疗效分析

1文献来源Xu B,Zhang Q,Zhang P,et al.Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer:a randomized,phase 3 trial[J].Nat Med,2021,27(11):1904-1909.2证据水平1b。